
Rosie Bradbury
Senior Venture Capital Reporter at PitchBook
senior reporter @PitchBook covering VC + startups / work in @WIRED @TIME @verge @businessinsider / DM for Signal 📩 [email protected] / she/her
Articles
-
20 hours ago |
pitchbook.com | Rosie Bradbury
Max Brodeur-Urbas’ Gumloop, has an ambitious goal: reach a $1 billion valuation with just 10 people on its full-time staff. Right now, it has nine. The two-year-old AI-enabled workflow automation startup, a Y Combinator graduate backed by First Round Capital and Nexus Venture Partners, is taking the aspirational Silicon Valley concept of a “10x engineer” and extending it to its logical conclusion: Creating a billion-dollar company can be done with a few extremely efficient people.
-
2 weeks ago |
pitchbook.com | Rosie Bradbury
The recent decadelong market boom propelled venture capital’s cultural status, luring droves of young finance workers whose jobs the industry can no longer afford. Over two years on, as liquidity remains elusive, more and more junior investors are seeing the writing on the wall and exploring new directions for their careers.
-
2 weeks ago |
pitchbook.com | Rosie Bradbury
Felicis has closed $900 million for its Fund X to capitalize on AI, the firm said Thursday. While some VC firms have scaled back their new fund targets in light of the market challenges, Felicis’ latest vehicle is its largest to date. It’s also a sign that some early-stage firms are accumulating more capital to compete with the larger multi-stage firms of the venture world.
-
3 weeks ago |
pitchbook.com | Rosie Bradbury
VC funds investing in biotech have fallen to their lowest fundraising levels in over a decade, according to a new PitchBook analysis. From its peak in 2018, fundraising by biotech investors has fallen 92% in total capital committed and has continued to decline despite fundraising recovering in other sectors. So far this year, biotech funds have comprised just 3% of venture capital raised across the asset class.
-
3 weeks ago |
pitchbook.com | Rosie Bradbury
VCs need to step up their support of American scientists whose federal research funding has been cut, Lux Capital co-founder Peter Hébert told PitchBook. As its latest move on this front, Lux is backing Roadrunner Venture Studios, a new accelerator-like program to help startups incubated out of national labs in New Mexico, including Los Alamos and Sandia.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 886
- DMs Open
- Yes

Not all VCs are happy about DOGE's federal funding cuts! Lux's Peter Hébert told me he thinks VCs should be doing more to help scientists caught in the crosshairs https://t.co/BS9QP1acKu

RT @drewfallon12: Prediction: The Farmer's Dog is the next big IPO in consumer in the next 12 months 👀 The Farmer's Dog is the hottest con…

RT @ByMikeBaker: The disparity has grown even further. New federal data shows that the United States now has: • 41,550 journalists • 280,59…